Press Releases

Ryan Moore Joins Benesch

July 13, 2017

Benesch is pleased to announce that Ryan Moore has joined the firm.

Ryan is a corporate and securities associate who concentrates his practice on middle market mergers and acquisitions for privately-held businesses and private equity funds, corporate governance issues, and general corporate law matters for private equity funds, their portfolio companies, and other public and privately-held businesses. Ryan often serves as outside general counsel for privately-held middle market and public company clients, providing general business counseling on day-to-day contract and general corporate matters and has extensive experience with contract term and conditions related to services, distribution, manufacturing and supply agreements. He received his J.D. from the John Marshall Law School and his B.S. from the University of Illinois.

Since January 2015, Benesch has welcomed over 83 new attorneys, 35 staff members and opened a new office in Chicago. The strategic addition of these attorneys and offices is another step in executing the firm’s aggressive growth plan and goal to continuously enhance the quality of service provided to clients.

Latest News

Press Releases 6.2.26

Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First

Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.

Press Releases 5.20.26

Daily Journal Names Benesch Partner Charan Brahma a 2026 Top Intellectual Property Lawyer

Benesch is pleased to announce that Intellectual Property Partner Charan Brahma has been named to the Daily Journal’s 2026 Top Intellectual Property Lawyers list. Charan focuses his practice on patent litigation and a range of intellectual property matters, primarily representing pharmaceutical and technology clients. With a strong trial focus, he works closely with clients to develop efficient litigation strategies aligned with their business objectives.